Back

Thrombocytopenia after transcatheter aortic valve implantation: prognostic value and mechanisms.

18 March 2022 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: e-Posters session Noncoronary Cardiac Intervention ACVC Premium Access ESC Acute CardioVascular Care 2022

About the speaker

Photo
Mr Carlos Roca Guerrero

Hospital Clinic, University of Barcelona, Barcelona (Spain)

90 More presentations in this session

Presentation thumbnail
Time is kidney: relation between pain-to-balloon time and acute kidney injury among ST segment elevation myocardial infarction patients undergoing primary percutaneous intervention
Doctor D. Zahler (Tel Aviv, IL)
Abstract Slides
Presentation thumbnail
Clinical utility of the SCAI classification in cardiogenic shock patients of any etiology treated by a multidisciplinary team.
Miss S. Lozano Jimenez (Majadahonda, ES)
Abstract Slides
Presentation thumbnail
Heart failure correction in patients with chronic renocardiac syndrome
Mr A. Demikhov (Sumy, UA)
Abstract Slides
Presentation thumbnail
Features of vascular motor endothelial function in hypertensive patients with chronic heart failure
Mr A. Demikhov (Sumy, UA)
Abstract Slides
Presentation thumbnail
Correlation of cholesterol efflux capacity with femoral and carotid plaque volume measured by sonographic 3D plaque volumetry
Doctor M. Noflatscher (Innsbruck, AT)
Abstract Slides

Access the full session

Session thumbnail
e-Posters session

The Event

Event poster

ESC Acute CardioVascular Care 2022

18 March 2022 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Thrombocytopenia following implantation of different types of bioprosthetic aortic valves in severe aortic valve stenosis replacement
28 August 2022
thumbnail
Congress Presentation
Outcome predictors in acute coronary syndrome in patients submitted to percutaneous coronary intervention
15 March 2025
thumbnail
Congress Presentation
Long-term survival and ourtomes a large cohort of patients underwent with Transcatheter Aortic Valve Replacement: An 10-year single center TAVR experience
28 August 2022
thumbnail
Congress Presentation
Effectiveness of the electrophysiological study for risk stratification of conduction disturbances after transcatheter aortic valve implantation
13 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources